Skip to content

US · HSDT · MEDICAL - DEVICES

Solana Company (HSDT) intrinsic value and stock valuation

$1.49as of 2026-11-21 · Mkt cap 100.43M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Solana Company DCF and intrinsic value

InvestorsCraft values HSDT with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from HSDT’s statements →

Solana Company Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Devices Newtown, PA 18940 solanacompany.co

How the business is doing

Fiscal 2013–2025, USD

Revenue
$6.02M+55.6% 5y CAGRd
20132025
Net income
-$-40.89M
20132025
Free cash flow
-$-61.29M
20132025
Total equity
$300.9M+138.9% 5y CAGRd
20142025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2013–2025, USD
20252024202320222021
Revenue$6.02M$520K$640K$790K$520K
Operating income-$-21.12M-$-13.9M-$-12.43M-$-15.52M-$-18.14M
Net income-$-40.89M-$-11.74M-$-8.85M-$-14.07M-$-18.13M
EPSd-$-1.85M-$-4.33M-$-7.25M-$-26.06M-$-181.3M
Operating cash flow-$-16.51M-$-11.04M-$-10.42M-$-14.31M-$-13.39M
Capital expenditure-$-44.78M-$-10K-$-30K-$-20K-$-50K
Free cash flow-$-61.29M-$-11.05M-$-10.45M-$-14.33M-$-13.44M
Total assets$303.9M$3.54M$7.69M$17.3M$14.1M
Total debt$0.00$10K$60K$110K$0.00
Net debt-$-7.28M-$-1.08M-$-5.12M-$-14.44M-$-11M
Total equity$300.9M$1.06M$2.35M$8.15M$11.3M
Cash and short-term investments$7.28M$1.09M$5.18M$14.6M$11M
Income statement
20252024202320222021
Revenue$6.02M$520K$640K$790K$520K
Cost of revenue$500K$580K$580K$460K$300K
Gross profit$5.52M-$-60K$60K$320K$220K
Research and development expenses$3.51M$3.66M$2.94M$4.26M$5.99M
Selling, general and administrative expenses$23.1M$10.1M$9.27M$10.6M$12.2M
Other expenses$0.00$60K$280K$940K$200K
Operating expenses$26.6M$13.8M$12.5M$15.8M$18.4M
Cost and expenses$27.1M$14.4M$13.1M$16.3M$18.7M
Interest income$0.00$0.00$260K$0.00$0.00
Interest expense$640K$20K$0.00$830K$0.00
Depreciation and amortization$680K$60K$160K$260K$310K
Ebitda-$-39.58M-$-13.8M-$-12.11M-$-14.5M-$-17.82M
Operating income-$-21.12M-$-13.9M-$-12.43M-$-15.52M-$-18.14M
Total other income/expenses, net-$-19.77M$2.16M$3.58M$1.44M$10K
Income before tax-$-40.89M-$-11.74M-$-8.85M-$-14.07M-$-18.13M
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income-$-40.89M-$-11.74M-$-8.85M-$-14.07M-$-18.13M
Weighted average shares outstanding$22.1M$2.71M$1.22M$540K$100K
Weighted average diluted shares outstanding$22.1M$2.71M$1.22M$540K$100K
Balance sheet
20252024202320222021
Cash and short-term investments$7.28M$1.09M$5.18M$14.6M$11M
Net receivables$0.00$640K$640K$340K$250K
Inventory$1.12M$1.09M$460K$590K$480K
Total current assets$31.2M$3.42M$7.3M$16.7M$12.6M
Property, plant and equipment, net$0.00$120K$230K$450K$410K
Goodwill and intangible assets$196.7M$0.00$20K$140K$1.1M
Long-term investments$76M$0.00$0.00$0.00$0.00
Total non-current assets$272.8M$120K$390K$590K$1.51M
Total assets$303.9M$3.54M$7.69M$17.3M$14.1M
Accounts payable$1.89M$870K$530K$630K$1.07M
Short-term debt$0.00$10K$40K$50K$0.00
Deferred revenue$0.00$40K$40K$30K$150K
Total current liabilities$3.02M$2.16M$1.88M$1.99M$2.65M
Long-term debt$0.00$0.00$10K$60K$0.00
Deferred revenue, non-current$0.00$80K$130K$170K$190K
Total non-current liabilities$0.00$320K$3.46M$7.15M$190K
Capital lease obligations$0.00$10K$10K$60K$0.00
Total liabilities$3.02M$2.48M$5.34M$9.14M$2.85M
Common stock$40K$0.00$0.00$30K$0.00
Retained earnings-$-212.59M-$-171.7M-$-159.96M-$-151.11M-$-137.03M
Accumulated other comprehensive income (loss)-$-260K$330K-$-670K-$-390K-$-1.12M
Total equity$300.9M$1.06M$2.35M$8.15M$11.3M
Total investments$76M$0.00$0.00$0.00$0.00
Total debt$0.00$10K$60K$110K$0.00
Net debt-$-7.28M-$-1.08M-$-5.12M-$-14.44M-$-11M
Cash flow statement
20252024202320222021
Net income-$-40.89M-$-11.74M-$-8.85M-$-14.07M-$-18.13M
Depreciation and amortization$680K$60K$160K$310K$370K
Stock-based compensation$9.25M$2.52M$1.63M$0.00$0.00
Change in working capital$230K-$-10K-$-310K-$-1.31M$130K
Accounts receivable$0.00-$-10K-$-290K-$-100K$0.00
Inventory-$-90K-$-610K$140K-$-110K-$-90K
Accounts payable$1.02M$340K-$-100K-$-420K$370K
Net cash provided by operating activities-$-16.51M-$-11.04M-$-10.42M-$-14.31M-$-13.39M
Investments in property, plant and equipment$0.00-$-10K-$-30K-$-20K-$-60K
Acquisitions, net$0.00$0.00$0.00$10K$0.00
Net cash used for investing activities-$-426.53M-$-10K-$-30K-$-10K-$-60K
Common stock issued$467M$6.95M$1.08M$17.9M$21.1M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$449.2M$6.95M$1.08M$17.9M$21.1M
Net change in cash$6.19M-$-4.09M-$-9.37M$3.54M$7.67M
Cash at end of period$7.28M$1.09M$5.18M$14.6M$11M
Operating cash flow-$-16.51M-$-11.04M-$-10.42M-$-14.31M-$-13.39M
Capital expenditure-$-44.78M-$-10K-$-30K-$-20K-$-50K
Free cash flow-$-61.29M-$-11.05M-$-10.45M-$-14.33M-$-13.44M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Solana Company

        Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.

        CEO
        Dane Carl Andreeff
        Employees
        21
        Beta
        1.03

        Explore

        Frequently asked questions

        What is the intrinsic value of Solana Company (HSDT)?

        InvestorsCraft does not currently publish an intrinsic value for HSDT. How the IC value is calculated.

        Is HSDT undervalued?

        InvestorsCraft does not publish an undervaluation signal for HSDT at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.